Related by context. Frequent words. (Click for all words.) 66 identify protein biomarkers 65 regulate therapeutically important 64 diagnostic biomarkers 63 VEGFR2 inhibitor 63 CD# expressing 62 novel orally administered 62 multi kinase inhibitor 61 inhibit angiogenesis 61 EGFR pathway 61 lung pancreatic 61 active cellular immunotherapy 60 selectively inhibit 60 proteasome inhibitor 60 CYC# 60 molecular biomarkers 60 organ transplant rejection 59 oncolytic viruses 59 TLR8 59 novel antibody therapeutics 58 MEK inhibitors 58 B lymphocyte stimulator 58 novel anticancer 58 immunologic diseases 58 G Protein Coupled 58 Met receptor tyrosine 58 immune modulating 58 targeting CD# 58 dependent cellular cytotoxicity 58 therapeutic monoclonal antibodies 58 protein secreted 58 Wnt signaling pathway 58 inflammatory autoimmune diseases 57 poly ADP ribose polymerase 57 histone deacetylase inhibitors 57 investigational therapies 57 autoreactive T cells 57 Panzem R NCD 57 PI3 kinase 57 TLR9 agonists 57 JAK1 57 Epidermal Growth Factor Receptor 57 multiple simultaneous immunological 57 FGFR 57 intracellular signaling pathways 56 drug conjugate 56 optical biosensors 56 Interferons 56 Sangamo ZFP technology 56 chemokine receptor 56 selective inhibition 56 molecularly targeted 56 proteasome inhibitors 56 potently silencing specific 56 potent inhibitors 56 anti angiogenic drugs 56 Vytorin combines 56 nitric oxide donating 56 anti mitotic 56 enzyme inhibitor 56 IMC #B 56 promising anticancer 56 hypoxia inducible factor 56 HCV replication 55 cancer immunotherapies 55 ImmunoGen proprietary 55 TLR9 agonist 55 epothilones 55 topically delivered 55 Nanobody 55 gastrointestinal mucositis 55 phage display 55 cardiac myosin 55 Tarvacin TM 55 virally infected cells 55 refractory chronic lymphocytic 55 SIRT1 activators 55 Trofex 55 R sorafenib tablets 55 Thiarabine 55 Panzem R 55 AEG# 55 adenoviral 55 coupled receptor GPCR 55 FLT3 55 bacterial enzyme 55 vitro assay 55 Sapacitabine 55 BiTE R 55 histone deacetylase 55 inflammation autoimmune diseases 55 mTOR inhibitors 54 splice variants 54 predictive biomarkers 54 MAbs 54 immunotherapeutic 54 fusion inhibitor 54 induce apoptosis 54 defensins 54 immunological diseases 54 Emergent marketed 54 Daclizumab